Annual Short Term Debt
N/A
July 31, 2024
Summary
- BCTX annual short term debt is not available.
Performance
BCTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Short Term Debt
N/A
October 31, 2024
Summary
- BCTX quarterly short term debt is not available.
Performance
BCTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
BCTX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
BCTX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
BriaCell Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2021 | - | $386.60 K(+49.4%) |
| Oct 2020 | - | $258.80 K(+3.6%) |
| Jul 2020 | $249.80 K(-22.5%) | $249.80 K(+16.5%) |
| Apr 2020 | - | $214.50 K(+42.4%) |
| Jan 2020 | - | $150.60 K(-53.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2019 | $322.50 K(-71.2%) | $322.50 K(+3.5%) |
| Apr 2019 | - | $311.50 K(-36.6%) |
| Jan 2019 | - | $491.30 K(-40.5%) |
| Oct 2018 | - | $825.40 K(-26.3%) |
| Jul 2018 | $1.12 M | $1.12 M(+14.4%) |
| Apr 2018 | - | $979.70 K |
FAQ
- What is the all time high annual short term debt for BriaCell Therapeutics?
- What is the all time high quarterly short term debt for BriaCell Therapeutics?
What is the all time high annual short term debt for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual short term debt is $1.12 M
What is the all time high quarterly short term debt for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly short term debt is $1.12 M